Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

Compass Therapeutics, Inc. CMPX

Set alert

Price alert · CMPX

All alert types
0.79 USD +0.03 +4.01%

At close · Oct 30

0.80 +0.01 +1.72%

After hours · Oct 30, 6:40 PM ET

Bid
0.79 × 2
Ask
0.80 × 2
0.7408 Day range 0.7969
0.747 52-week range 6.69
YTD
-85.35%
1 year
-78.86%
Open
0.756
Prev close
0.7562
Mkt cap
141.64M
Vol
2.92M
Avg vol
4.27M
EPS
-0.39
P/E
0.00
Div yield
0.00%
More statistics
Low
0.7408
High
0.7969
Forward P/E
-10.86
Beta
1.30
Short ratio
12.39
Inst. own
88.00%
Dividend
0.00
Ex-div date
50-d avg
5.68
200-d avg
4.58
1y target
13.64

3M chart

Chart tools
Interval
1m5m15m30m

Signals (8)
NameDateAgo
MACD: Buy SignalOct 9, 20263 weeks ago
RSI: OversoldSep 22, 20261 month ago
SMA: BearishSep 8, 20261 month ago
SMA: BearishSep 8, 20261 month ago
MACD: Sell SignalSep 1, 20262 months ago
SMA: BullishAug 7, 20262 months ago
SMA: BullishAug 7, 20262 months ago
MACD: Buy SignalAug 7, 20262 months ago

Financial health

Altman Z-Score

-0.21 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 3

Valuation

P/E -12.8×
FY 2018: -1.1×FY 2019: -12.7×FY 2020: -16.3×FY 2021: -2.4×FY 2022: -14.4×FY 2023: -4.7×FY 2024: -4.0×FY 2025: -12.8×
FY 2018 5y median -4.7× FY 2025
P/S 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 234×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025
P/B 4.3×
FY 2018: -0.5×FY 2019: -3.7×FY 2020: 12.0×FY 2021: 1.4×FY 2022: 2.9×FY 2023: 1.3×FY 2024: 1.6×FY 2025: 4.3×
FY 2018 5y median 1.6× FY 2025
P/FCF -17.2×
FY 2018: -1.2×FY 2019: -13.8×FY 2020: -17.8×FY 2021: -9.4×FY 2022: -15.4×FY 2023: -4.9×FY 2024: -4.4×FY 2025: -17.2×
FY 2018 5y median -9.4× FY 2025
EV/EBITDA -12.7×
FY 2018: 0.0×FY 2019: -13.5×FY 2020: -17.3×FY 2021: -0.7×FY 2022: -14.2×FY 2023: -4.3×FY 2024: -3.4×FY 2025: -12.7×
FY 2018 5y median -4.3× FY 2025
EV/Sales 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 191×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025
FCF Yield -5.8%
FY 2018: -84.0%FY 2019: -7.3%FY 2020: -5.6%FY 2021: -10.7%FY 2022: -6.5%FY 2023: -20.5%FY 2024: -22.6%FY 2025: -5.8%
FY 2018 5y median -10.7% FY 2025

Profitability

Gross Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 100.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: -6661.8%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: -5808.8%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
ROE -33.8%
FY 2018: 45.2%FY 2019: 29.3%FY 2020: -73.9%FY 2021: -58.7%FY 2022: -21.6%FY 2023: -28.6%FY 2024: -39.4%FY 2025: -33.8%
FY 2018 5y median -33.8% FY 2025
ROIC -35.3%
FY 2018: -64.0%FY 2019: -130.3%FY 2020: -56.4%FY 2021: -56.8%FY 2022: -22.6%FY 2023: -33.5%FY 2024: -42.9%FY 2025: -35.3%
FY 2018 5y median -35.3% FY 2025
ROA -30.3%
FY 2018: -59.2%FY 2019: -114.4%FY 2020: -56.8%FY 2021: -53.4%FY 2022: -19.6%FY 2023: -27.1%FY 2024: -35.2%FY 2025: -30.3%
FY 2018 5y median -30.3% FY 2025

Growth (YoY)

Revenue -100.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: -100.0%
FY 2018 FY 2025
Operating Income -28.6%
FY 2018: 0.0%FY 2019: 11.1%FY 2020: 18.3%FY 2021: -194.4%FY 2022: 49.1%FY 2023: -20.9%FY 2024: -12.4%FY 2025: -28.6%
FY 2018 FY 2025
EPS (diluted) -16.7%
FY 2018: 0.0%FY 2019: 91.3%FY 2020: 22.4%FY 2021: -151.9%FY 2022: 73.3%FY 2023: 5.7%FY 2024: -9.1%FY 2025: -16.7%
FY 2018 FY 2025
Free Cash Flow -9.5%
FY 2018: 0.0%FY 2019: 9.8%FY 2020: 16.4%FY 2021: 21.1%FY 2022: -61.7%FY 2023: -18.4%FY 2024: -10.5%FY 2025: -9.5%
FY 2018 FY 2025

Financial Health

Current Ratio 15.0×
FY 2018: 7.0×FY 2019: 2.7×FY 2020: 5.0×FY 2021: 13.8×FY 2022: 12.0×FY 2023: 19.7×FY 2024: 15.0×FY 2025: 15.0×
FY 2018 5y median 15.0× FY 2025
Quick Ratio 15.0×
FY 2018: 7.0×FY 2019: 2.7×FY 2020: 5.0×FY 2021: 13.8×FY 2022: 12.0×FY 2023: 19.7×FY 2024: 15.0×FY 2025: 15.0×
FY 2018 5y median 15.0× FY 2025
Debt / Equity 0.0×
FY 2018: -0.2×FY 2019: -0.1×FY 2020: 0.2×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.1×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025
Net Debt / EBITDA 0.3×
FY 2018: 1.2×FY 2019: 0.3×FY 2020: 1.5×FY 2021: 1.8×FY 2022: 0.9×FY 2023: 0.6×FY 2024: 0.8×FY 2025: 0.3×
FY 2018 5y median 0.8× FY 2025
Interest Coverage 0.0×
FY 2018: -50.0×FY 2019: -27.7×FY 2020: -30.6×FY 2021: -221×FY 2022: -17.7×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31